# Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer

> **NCT07408505** · NA · RECRUITING · sponsor: **Shandong Cancer Hospital and Institute** · enrollment: 56 (estimated)

## Conditions studied

- Advanced Pancreatic Ductal Adenocarcinoma
- Cancer Anorexia-Cachexia Syndrome

## Interventions

- **DRUG:** Nano-crystalline megestrol acetate
- **DRUG:** First-line Chemotherapy

## Key facts

- **NCT ID:** NCT07408505
- **Lead sponsor:** Shandong Cancer Hospital and Institute
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-06-01
- **Primary completion:** 2027-12-30
- **Final completion:** 2028-02-20
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-04-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07408505

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07408505, "Nano-Megestrol Acetate for Cancer Cachexia in Advanced Pancreatic Cancer". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT07408505. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*